Clifton David Fuller
Overview
Explore the profile of Clifton David Fuller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
730
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anyimadu E, Wang Y, Floricel C, Kamel S, Fuller C, Zhang X, et al.
IEEE J Biomed Health Inform
. 2025 Mar;
PP.
PMID: 40030567
Patient-Reported Outcomes (PRO) consist of information provided directly by the patients about their health status including symptom ratings. PROs are commonly used in clinical practice to support clinical decisionmaking and...
2.
Rigert J, Kaffey Z, Belal Z, Tripuraneni L, Humbert-Vidan L, Sahli A, et al.
medRxiv
. 2025 Feb;
PMID: 39974112
Objective: Osteoradionecrosis of the jaw (ORNJ) is a chronic radiation-associated toxicity that lacks standardized classification criteria and treatment guidelines. Understanding early signs of tissue injury could help us better predict,...
3.
Sherry A, Msaouel P, Lin T, Abi Jaoude J, Kouzy R, Beck E, et al.
BMJ Oncol
. 2025 Jan;
3(1):e000322.
PMID: 39886131
Objective: Estimations of the treatment effect on overall survival (OS) may be influenced by post-progression therapies (PPTs). It is unclear how often OS analyses account for PPT effects. The purpose...
4.
Moreno A, Watson E, Humbert-Vidan L, Peterson D, van Dijk L, Urbano T, et al.
Int J Radiat Oncol Biol Phys
. 2025 Jan;
PMID: 39826846
Purpose: Osteoradionecrosis of the jaw (ORNJ) is a severe iatrogenic disease characterized by bone death after radiation therapy (RT) to the head and neck. With over 9 published definitions and...
5.
Mao S, Wang J, McMillan H, Mohamed A, Buoy S, Ahmed S, et al.
Head Neck
. 2025 Jan;
PMID: 39794912
Background: Quantifying head and neck lymphedema and fibrosis (HN-LEF) is crucial in the investigation and management of treatment sequelae in head and neck cancer (HNC). Methods: The T1- and T2-weighted...
6.
Yaniv D, Niccolai L, Wefel J, Sullaway C, Phan J, Fuller C, et al.
J Neurol Surg B Skull Base
. 2024 Nov;
85(6):614-621.
PMID: 39483162
Few recent studies have examined neurocognitive functioning (NCF) in patients with sinonasal and nasopharyngeal cancers (NPCs) prior to and following multimodality therapy or the potential differences in NCF by disease...
7.
Anyimadu E, Fuller C, Zhang X, Marai G, Canahuate G
Database Expert Syst Appl (2024)
. 2024 Oct;
14910:231-248.
PMID: 39463781
This study addresses the prevalent issue of missing data in patient-reported outcome datasets, particularly focusing on head and neck cancer patient symptom ratings sourced from the MD Anderson Symptom Inventory....
8.
Sherry A, Lin T, McCaw Z, Beck E, Kouzy R, Abi Jaoude J, et al.
Int J Radiat Oncol Biol Phys
. 2024 Oct;
120(5):1239-1244.
PMID: 39352322
Purpose: Increasing data suggest that radiation therapy, particularly ablative radiation therapy, alters the natural history of metastatic disease. For patients with metastatic disease enrolled in prospective trials testing systemic therapy,...
9.
Wentzel A, Attia S, Zhang X, Canahuate G, Fuller C, Marai G
IEEE Trans Vis Comput Graph
. 2024 Sep;
31(1):65-75.
PMID: 39255169
Digital twin models are of high interest to Head and Neck Cancer (HNC) oncologists, who have to navigate a series of complex treatment decisions that weigh the efficacy of tumor...
10.
Sherry A, Lin T, McCaw Z, Beck E, Kouzy R, Abi Jaoude J, et al.
Int J Cancer
. 2024 Aug;
155(11):1939-1943.
PMID: 39138841
Disease progression in clinical trials is commonly defined by radiologic measures. However, clinical progression may be more meaningful to patients, may occur even when radiologic criteria for progression are not...